The Market for Next-Generation-Sequencing Neonatal Testing (NGS-NIPT) in China
Next Generation NIPT Sequencing in China estimates the revenues for non-invasive prenatal testing in this emerging market, and generally analyzes the role of next generation sequencing (NGS) in the country. Estimates in this report include revenues for non-invasive prenatal testing using sequencing in China, projections to 2020, market share. Institutions performing NGS and key equipment manufacturers and service providers are discussed.
This report was created as a cooperative project between Kalorama Information and The Freedonia Group, with staff from Freedonia’s Beijing office completing primary and secondary research.
- Executive Summary
- Scope and Methodology
- Major Findings of The Report
- Introduction
- China in Perspective
- Table Provinces of China
- Population Trends and Demographics
- Aging of Population
- Growing Chinese Hospital Sector
- Number of Hospitals in China, 2004 2015
- Table Hospitals in China 2004-2015
- Hospitals in China by Class (Class I, Class II, Class III)
- Table Hospitals in China by Type (Class I, Class II, Class III)
- Resource Constraints in Hospitals
- Number of Hospitals in China, 2004 2015
- Intellectual Property Issues
- Higher Out of Pocket Spending in China
- Percent of Spending Out of Pocket: China vs. Other Nations
- Table Percent of Healthcare Spending Out of Pocket
- Percent of Spending Out of Pocket: China vs. Other Nations
- Healthcare Reform
- Disease Costs
- Sequencing Introduction
- Sanger
- Next Generation Sequencing
- Sequencing in China
- Products Approved
- Table Next Generation Sequencing Products Approved in China
- Institutions Performing NGS in China
- Table Chinese Institutions Approved for Next Generation Sequencing.
- Technologies Used for Newborn Screening
- Traditional Tests
- Sequencing
- China in Perspective
- Market Analysis
- Introduction
- Relevant Demographics
- Table Relevant Demographics
- Relevant Demographics
- Hospital Use of NGS
- Hospitals Using NGS: Outsourced vs. In House
- Table Penetration of NGS – NIPT in China Hospital
- Hospitals Using NGS: Outsourced vs. In House
- Major Competitors
- Leading Companies in Next Generation Sequencing in China (Equipment Providers, TestMakers, Service Providers)
- Table Leading Companies in Next Generation Sequencing in China
- Leading Companies in Next Generation Sequencing in China (Equipment Providers, TestMakers, Service Providers)
- Chinese NGS NIPT Market
- Market Size and Forecast to 2020
- Table NGS NIPT Market in China
- Market Share of NGS NIPT in China and Competitive Analysis
- Table Market Share in Next Generation Sequencing in China
- Emerging NGS Applications in China
- Market Size and Forecast to 2020
- Introduction
- NGS Competitors in China
- Annoroad
- Amoy Diagnostics Co., LTD
- Berry Genomics Co. Ltd
- Beijing Genomics Institute (BGI)
- CapitalBio Corporation
- Novogene
- Daan Gene Co., Ltd.
- Shanghai Kehua Bio engineering
- Zhejiang Dian Diagnostics
- Wuxi AppTec Co. LTD.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook